Astellas Pharma Inc. (TYO:4503)
2,355.50
-61.50 (-2.54%)
Sep 4, 2026, 3:30 PM JST
Astellas Pharma Market Cap
Astellas Pharma has a market cap or net worth of 4.22 trillion as of September 4, 2026. Its market cap has increased by 41.77% in one year.
Market Cap
4.22T
Enterprise Value
4.57T
Revenue
2.27T
Ranking
n/a
PE Ratio
11.60
Stock Price
2,355.50
ChartMarket Cap Chart
Since January 14, 1992, Astellas Pharma's market cap has increased from 882.84B to 4.22T, an increase of 378.39%. That is a compound annual growth rate of 4.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 4.22T | 12.65% |
| Dec 30, 2025 | 3.75T | 36.48% |
| Dec 30, 2024 | 2.75T | -9.13% |
| Dec 29, 2023 | 3.02T | -17.34% |
| Dec 30, 2022 | 3.66T | 5.52% |
| Dec 30, 2021 | 3.47T | 17.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 11.24T |
| Takeda Pharmaceutical Company | 9.30T |
| HOYA Corporation | 8.17T |
| Otsuka Holdings | 6.40T |
| Daiichi Sankyo Company | 5.25T |
| Terumo | 3.64T |
| Shionogi & | 2.54T |
| Olympus | 2.22T |